Silo Pharma, Inc. (SILO)
NasdaqCM: SILO
· Real-Time Price · USD
2.48
-0.03 (-1.20%)
At close: Aug 31, 2026, 3:43 PM
The price, the headline numbers and the latest news, in one place.
Silo Pharma, Inc. (SILO) Stock Price, Analysis & Data
-1.25% (1D)
| Bid | 1.83 |
| Market Cap | 4.37M |
| Revenue (ttm) | 54.1K |
| Net Income (ttm) | -4.47M |
| 0.80 | |
| -3.74 | |
| n/a | |
| -3.56 | |
| P/B (ttm) | 0.48 |
| P/S (ttm) | 80.73 |
| Earnings Date | n/a |
| Ask | 3.21 |
| Volume | 22,248 |
| Avg. Volume (20D) | 198,987 |
| Open | 2.48 |
| Previous Close | 2.51 |
| Day's Range | 2.47 - 2.55 |
| 52-Week Range | 2.43 - 15.15 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About SILO
Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company's lead program, SPC-15, is an intranasal treatment t...
Industry Biotechnology
Sector Healthcare
IPO Date Jan 8, 2021
Employees 3
Stock Exchange NasdaqCM
Ticker Symbol SILO
Website https://silopharma.com
Financial Performance
In 2025, Silo Pharma's revenue was 72.1K, an increase of 0% compared to the previous year's 72.1K. Earnings were -4.23M, a decrease of -3.76%.
Financial StatementsEarnings Surprise
Silo Pharma has released their quarterly earnings on Mar 25, 2024:
- Revenue of $18.03K misses estimates by $0, with 0.00% YoY growth.
- EPS of -5.4 misses estimates by -2.40, with -Infinity% YoY decline.
Page 1 of 2